The chemotherapeutic agent DMXAA as a unique IRF3-dependent type-2 vaccine adjuvant.

5,6-Dimethylxanthenone-4-acetic acid (DMXAA), a potent type I interferon (IFN) inducer, was evaluated as a chemotherapeutic agent in mouse cancer models and proved to be well tolerated in human cancer clinical trials. Despite its multiple biological functions, DMXAA has not been fully characterized...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Choon Kit Tang, Taiki Aoshi, Nao Jounai, Junichi Ito, Keiichi Ohata, Kouji Kobiyama, Benoit H Dessailly, Etsushi Kuroda, Shizuo Akira, Kenji Mizuguchi, Cevayir Coban, Ken J Ishii
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Public Library of Science (PLoS) 2013-01-01
Serie:	PLoS ONE
Accesso online:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23555875/?tool=EBI
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!